Form 4 for ALKS Alkermes plc.
Accepted 2024-11-06 00:00:00 ET · period of report 2024-11-06 · accession 0001127602-24-026629 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-06 | 2024-11-06 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | S - Sale | $29.53 | -10.5K | 99.2K | -10% | -$309.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-11-06 | S | D | 10,471 | $29.53 | 99,238 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.50 to $29.61. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. |